DaVita (DVA) Q2 2025 10-Q Quarterly Report
Filed: Aug 5, 2025Period ending Jun 30, 2025
Health Care
Services-Misc Health & Allied Services, NECSEC EDGAR DaVita (DVA) 10-Q quarterly report for Q2 2025, filed with SEC EDGAR on Aug 5, 2025 for the fiscal period ending Jun 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
DaVita Q2 2025 10-Q Analysis
Risk Factors
- • New cybersecurity risk: $13M charges in Q2 2025 from incident remediation, excluded from non-GAAP results reflecting non-recurring nature
- • Updated tax risk: Effective income tax rate rose to 31.9% in Q2 2025 from 22.9% in H1 2024, driven by changes in tax expense allocation
DaVita Q2 2025 Quarterly FinancialsXBRL
Revenue
$3.4B
▲ +6.1% YoY▲ +4.8% QoQ
Net Income
$199M
▼ -10.5% YoY▲ +22.4% QoQ
Operating Margin
15.9%
▲ +2bp YoY▲ +230bp QoQ
Net Margin
5.9%
▼ -109bp YoY▲ +84bp QoQ
EPS (Diluted)
$2.57
▲ +2.8% YoY▲ +28.5% QoQ
Operating Cash Flow
$324M
▼ -59.4% YoY▲ +80.1% QoQ
Source: XBRL data from DaVita Q2 2025 10-Q filing on SEC EDGAR. All figures in USD.
Other DaVita Quarterly Reports
Get deeper insights on DaVita
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.